MoneyWorks4Me

Venus Remedies informs about outcome of board meeting

25 Jun 2016 Evaluate

Venus Remedies has informed that the Board of Directors of the Company at its meeting held on June 24, 2016, has considered that in the light of the delay in some pending permissions, the Board has decided to withdraw the proposal of Preferential Allotment of 900,000 equity shares of Rs 10 each approved at AGM held on August 25, 2015 with liberty to consider a fresh proposal of allotment of shares at an appropriate stage by placing the same before the general meeting.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..